Show notes are at https://stevelitchfield.com/sshow/chat.html
…
continue reading
Content provided by Academy of Technology and Engineering and Academy of Technology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Academy of Technology and Engineering and Academy of Technology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
TechNOW podcast: Breathable treatment for drug-resistant TB
MP3•Episode home
Manage episode 305801324 series 2350225
Content provided by Academy of Technology and Engineering and Academy of Technology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Academy of Technology and Engineering and Academy of Technology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
COVID isn’t the only pandemic threat we face. The infectious disease that killed the most people in 2018 wasn’t malaria or HIV: it was tuberculosis. Because of antibiotic resistance, a growing number of TB infections can’t be cured by current methods. Rising fever, chest-pain, coughing up blood – without new treatments, this ancient sickness could become a future crisis. But what if we could treat antibiotic resistant TB with a new drug delivered straight into the lungs by an asthma-puffer style device? Thanks to new technology developed by Associate Professor Charlotte Conn, her team at RMIT, and their collaborators in India, this dream cure could become a reality. TechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections fund – a project run by the Australian Academy of Technology and Engineering and supported by the Australian Government.
…
continue reading
11 episodes
MP3•Episode home
Manage episode 305801324 series 2350225
Content provided by Academy of Technology and Engineering and Academy of Technology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Academy of Technology and Engineering and Academy of Technology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
COVID isn’t the only pandemic threat we face. The infectious disease that killed the most people in 2018 wasn’t malaria or HIV: it was tuberculosis. Because of antibiotic resistance, a growing number of TB infections can’t be cured by current methods. Rising fever, chest-pain, coughing up blood – without new treatments, this ancient sickness could become a future crisis. But what if we could treat antibiotic resistant TB with a new drug delivered straight into the lungs by an asthma-puffer style device? Thanks to new technology developed by Associate Professor Charlotte Conn, her team at RMIT, and their collaborators in India, this dream cure could become a reality. TechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections fund – a project run by the Australian Academy of Technology and Engineering and supported by the Australian Government.
…
continue reading
11 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.